These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1234479)

  • 21. [Serum levels of beta-methyldigoxin and contractile efficiency of the myocardium evaluated with systolic polygraphy and determination of cardiac output].
    Pelosi G; Bracchi G; Orazio S; Cereda A
    Minerva Med; 1981 Feb; 72(4-5):225-31. PubMed ID: 7010220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of dynamic exercise on the behavior of the systolic time intervals in subjects with hypoxic myocardiopathy. II].
    Rengo F; De Caprio L; Ferro G; Vigorito C; Bonaduce D; Scarafile P; Critelli G; Vitale D
    Boll Soc Ital Cardiol; 1976; 21(1):99-112. PubMed ID: 1030986
    [No Abstract]   [Full Text] [Related]  

  • 23. [The pharmacology of the combination drug dilazep/beta-acetyldigoxin].
    Zechel VH; Brock N
    Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1905-14. PubMed ID: 4480353
    [No Abstract]   [Full Text] [Related]  

  • 24. [Therapy of coronary heart disease using Cormelian-Digotab. Results of a double blind study].
    Messerich J
    Fortschr Med; 1974 Nov; 92(33):1367-71. PubMed ID: 4457447
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of chronic oral digoxin therapy on ventricular function at rest and peak exercise in patients with ischemic heart disease.
    Firth BG; Dehmer GJ; Corbett JR; Lewis SE; Parkey RW; Willerson JT
    Am J Cardiol; 1980 Sep; 46(3):481-90. PubMed ID: 7415994
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of chronotropic incompetence and beta-blocker use on the exercise treadmill test in men.
    Gauri AJ; Raxwal VK; Roux L; Fearon WF; Froelicher VF
    Am Heart J; 2001 Jul; 142(1):136-41. PubMed ID: 11431669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [ECG studies of the resorption quota of the heart affecting glycosides].
    Schellhorn W; Kaltenbach M
    Med Klin; 1969 May; 64(18):832-6. PubMed ID: 5814962
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of exercise on left-ventricular systolic time intervals in patients with coronary heart disease.
    Markiewicz K; Cholewa M; Górski L; Gawor Z
    Acta Med Hung; 1987; 44(4):349-62. PubMed ID: 3444712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [On the metabolic and hemodynamic response of the coronary disease patients to progressive orthostatic muscular exercise (triangular test 10 watts-min)].
    Lixi M; Porrazzo G; Cherchi A; Esu MP; Sassu P
    Boll Soc Ital Cardiol; 1970 Jun; 14(6):821-38. PubMed ID: 5477899
    [No Abstract]   [Full Text] [Related]  

  • 30. [Comparative studies on the effects of oxyfedrine, epinephrine and digitalis glycosides on the function and high-energy phosphates of the guinea-pig heart].
    Kammermeier H; Bünger R; Ziegler V; Gerlach E
    Arzneimittelforschung; 1974 Jun; 24(6):928-32. PubMed ID: 4408043
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical trial of the new coronary dilator hexobendine].
    Henke C; Dudik E; Steim H
    Arzneimittelforschung; 1968 Aug; 18(8):1103-7. PubMed ID: 4885101
    [No Abstract]   [Full Text] [Related]  

  • 32. The effects of trimetazidine on heart rate variability in patients with slow coronary artery flow.
    Topal E; Ozdemir R; Barutcu I; Aksoy Y; Sincer I; Akturk E; Cehreli S
    J Electrocardiol; 2006 Apr; 39(2):211-8. PubMed ID: 16580422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hemodynamic changes following blockade of the beta-receptors in healthy persons and in patients with coronary heart disease. Comparison between Trasicor and Inderal].
    Bürgin D
    Schweiz Med Wochenschr; 1968 Jun; 98(25):940-5. PubMed ID: 5699197
    [No Abstract]   [Full Text] [Related]  

  • 34. [Behavior of different systolic periods during exercise test in hypertonic persons in the early stage of the disease].
    Lori M; Priebe U; Schmidt E
    Dtsch Gesundheitsw; 1971 Aug; 26(34):1577-82. PubMed ID: 5117093
    [No Abstract]   [Full Text] [Related]  

  • 35. [Adaptation of the circulatory system to physical exertion in patients with coronary disease and in healthy persons after administration of beta-methyldigoxin].
    Ziółkowski L; Wójcik-Ziółkowska E
    Pol Tyg Lek; 1986 Jan; 41(4):103-6. PubMed ID: 3703731
    [No Abstract]   [Full Text] [Related]  

  • 36. What maintains the metabolic cost at maximal exercise in heart transplant recipients and coronary artery disease patients?
    Sagiv M; Goldhammer E; Ben-Sira D; Amir R
    J Heart Lung Transplant; 2007 Jun; 26(6):617-21. PubMed ID: 17543786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contrasting effect on cardiac output of digoxin and gitoxin in humans during congestive heart failure.
    Col J; Wijns W; Brasseur L; Lesne M
    Int J Clin Pharmacol Ther Toxicol; 1981 Jul; 19(7):314-8. PubMed ID: 7263109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapy of coronary heart disease using Cormelian-Digotab. First communication on a field experiment of 107 residential physicians].
    Pollter J; Schnitker J
    Med Welt; 1975 Oct; 26(44):2007-12. PubMed ID: 1186488
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of digoxin on ventricular automaticity in Chagasic cardiomyopathy.
    Beer N; Puigbó JJ; Aparicio JM; Hirschhaut E; Valecillos R
    Postgrad Med J; 1977 Sep; 53(623):537. PubMed ID: 412176
    [No Abstract]   [Full Text] [Related]  

  • 40. Medigoxin (Lanitop) v. digoxin.
    Drug Ther Bull; 1977 Sep; 15(20):79-80. PubMed ID: 913248
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.